|
Learn about drugs and medical devices just approved by the U.S. Food and Drug Administration.
Gleevec Approval Widened to Include Rare Cancer (01-Feb-2012) Kalydeco Approved to Treat Rare Form of Cystic Fibrosis (31-Jan-2012) Erivedge Approved to Treat Basal Cell Carinoma (30-Jan-2012) Drug Approved for Advanced Kidney Cancer (27-Jan-2012) Bydureon Approved for Type 2 Diabetes (27-Jan-2012) First Test Approved to Help Detect Risk of Rare Brain Infection (20-Jan-2012) Voraxaze Approved to Treat High Levels of Chemo Drug (18-Jan-2012) Endovascular Graft Approved for Tears of Aorta (16-Jan-2012)
.
|
